2023
Treatment, Management, and Otolaryngology Consultation for Epistaxis in the Emergency Room: An Institutional Experience
Jacobs D, Wang V, Chao J, Manes R, Lee Y. Treatment, Management, and Otolaryngology Consultation for Epistaxis in the Emergency Room: An Institutional Experience. American Journal Of Rhinology 2023, 38: 102-107. PMID: 38155492, DOI: 10.1177/19458924231223348.Peer-Reviewed Original ResearchENT consultationWhite patientsNeck surgeryOutside facilityCommon reasonPatient careRecent headMore white patientsRetrospective chart reviewEmergency department visitsNon-white patientsClinical care pathwayNonabsorbable packingAdult patientsChart reviewED visitsDepartment visitsED encountersOtolaryngology consultationED settingCare pathwayEmergency roomInstitutional experienceEpistaxisAbnormal anatomy
2021
Adverse Events Associated With ClariFix Posterior Nasal Nerve Cryoablation: A MAUDE Database Analysis
Singh A, Kasle D, Torabi S, Manes R. Adverse Events Associated With ClariFix Posterior Nasal Nerve Cryoablation: A MAUDE Database Analysis. Otolaryngology 2021, 165: 597-601. PMID: 33528303, DOI: 10.1177/0194599820986581.Peer-Reviewed Original ResearchConceptsAdverse eventsMedical device reportsPNN cryoablationCommon adverse eventsMAUDE Database AnalysisNovel surgical techniqueDrug Administration ManufacturerChronic rhinitisCryosurgical ablationNasal swellingSurgical techniqueCryoablationDevice reportsDatabase analysisCertain populationsEpistaxisFurther studiesExperience databaseRhinitis
2016
A Patient With Pancytopenia, Intractable Epistaxis, and Metastatic Prostate Cancer: How Correct Diagnosis of Primary Hyperfibrinolysis Helps to Stop the Bleeding
Jafri MA, Cohen JV, Much MA, Petrylak DP, Podoltsev NA. A Patient With Pancytopenia, Intractable Epistaxis, and Metastatic Prostate Cancer: How Correct Diagnosis of Primary Hyperfibrinolysis Helps to Stop the Bleeding. Clinical Genitourinary Cancer 2016, 14: e545-e548. PMID: 27320762, DOI: 10.1016/j.clgc.2016.05.002.Peer-Reviewed Original Research
2015
Severe epistaxis due to aberrant vasculature in a patient with STAT‐1 mutation
Chang MT, Schwam ZG, Hajek MA, Paskhover B, Judson BL. Severe epistaxis due to aberrant vasculature in a patient with STAT‐1 mutation. Head & Neck 2015, 38: e68-e70. PMID: 26445901, DOI: 10.1002/hed.24165.Peer-Reviewed Original ResearchHemorrhage Rates From Brain Arteriovenous Malformation in Patients With Hereditary Hemorrhagic Telangiectasia
Kim H, Nelson J, Krings T, terBrugge K, McCulloch C, Lawton M, Young W, Faughnan M, Chakinala M, Gossage J, Henderson K, Iyer V, Kasthuri R, Lin D, Mager J, McWilliams J, McDonald J, Pawlikowska L, Pollak J, Ratjen F, Swanson K, Vethanayagam D, White A, White R, Wilcox P. Hemorrhage Rates From Brain Arteriovenous Malformation in Patients With Hereditary Hemorrhagic Telangiectasia. Stroke 2015, 46: 1362-1364. PMID: 25858236, PMCID: PMC4415515, DOI: 10.1161/strokeaha.114.007367.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAneurysm, RupturedChildChild, PreschoolCohort StudiesFemaleHumansInfantInfant, NewbornIntracranial Arteriovenous MalformationsIntracranial HemorrhagesMaleMiddle AgedRecurrenceRetrospective StudiesSocioeconomic FactorsSurvival AnalysisTelangiectasia, Hereditary HemorrhagicYoung AdultConceptsHereditary hemorrhagic telangiectasiaBrain arteriovenous malformationsICH rateArteriovenous malformationsHemorrhage rateHemorrhagic telangiectasiaHigher ICH ratesIntracranial hemorrhage rateMajority of patientsICH presentationSymptomatic casesSystemic diseaseICH eventsMean ageAsymptomatic screeningMucocutaneous telangiectasiaHHT patientsHigh riskUnruptured casesPatientsMalformationsDiagnosisTelangiectasiaRehemorrhageEpistaxis
2013
Intractable epistaxis and systemic lupus: High-dose intravenous pulse steroids
Waselchuk EA, Hildrew DM, Winters RD, Ellis MS. Intractable epistaxis and systemic lupus: High-dose intravenous pulse steroids. American Journal Of Otolaryngology 2013, 35: 236-238. PMID: 24411135, DOI: 10.1016/j.amjoto.2013.12.003.Peer-Reviewed Case Reports and Technical NotesConceptsSystemic lupus erythematosusIntravenous pulse steroid therapyPulse steroid therapyIntractable epistaxisSteroid therapyTreatment optionsSevere systemic lupus erythematosusIntravenous pulse steroidsSetting of comorbiditiesDevastating disease processNovel treatment optionsIntravenous dexamethasonePulse steroidsHospital courseConservative managementSystemic lupusLupus erythematosusMedical therapyCase reportEpistaxisDisease processPatientsPresumed mechanismTherapyFirst description
2012
The Young's Procedure for Severe Epistaxis from Hereditary Hemorrhagic Telangiectasia
Richer SL, Geisthoff UW, Livada N, Ward PD, Johnson L, Mainka A, Henderson KJ, Maune S, White RI, Ross DA. The Young's Procedure for Severe Epistaxis from Hereditary Hemorrhagic Telangiectasia. American Journal Of Rhinology 2012, 26: 401-404. PMID: 23168156, DOI: 10.2500/ajra.2012.26.3809.Peer-Reviewed Original ResearchConceptsHereditary hemorrhagic telangiectasiaSevere epistaxisYoung's procedureHemorrhagic telangiectasiaGlasgow Benefit Inventory scoreTransfusion-dependent patientsComplete cessationHHT CenterMost patientsSurgical treatmentPostoperative epistaxisSurgical closurePatient outcomesEfficacious procedureSubjective outcomesEpistaxisPatientsMean increaseSevere ironInventory scoresLaser proceduresCessationOutcomesTreatmentTelangiectasia
2010
Evaluating and Managing the Patient with Nosebleeds
Manes RP. Evaluating and Managing the Patient with Nosebleeds. 2010, 94: 903-912. PMID: 20736102, DOI: 10.1016/j.mcna.2010.05.005.Peer-Reviewed Original Research
2008
Long‐term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia
Levine CG, Ross DA, Henderson KJ, Leder SB, White RI. Long‐term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Otolaryngology 2008, 138: 721-724. PMID: 18503842, DOI: 10.1016/j.otohns.2008.01.005.Peer-Reviewed Original ResearchConceptsHereditary hemorrhagic telangiectasiaSeptal dermoplastyQuality of lifeHemorrhagic telangiectasiaConsecutive retrospective studyLong-term complicationsLife-threatening epistaxisTreatment of choiceNasal odorConsecutive patientsSinus infectionRetrospective studySense of smellDermoplastyPatientsEpistaxisPotential patientsComplicationsPhone interviewsImproved qualityTelangiectasiaInfection
2007
Septectomy and Septal Dermoplasty for the Treatment of Severe Transfusion-Dependent Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia and Septal Perforation
Lesnik GT, Ross DA, Henderson KJ, Joe JK, Leder SB, White RI. Septectomy and Septal Dermoplasty for the Treatment of Severe Transfusion-Dependent Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia and Septal Perforation. American Journal Of Rhinology 2007, 21: 312-315. PMID: 17621815, DOI: 10.2500/ajr.2007.21.3017.Peer-Reviewed Original ResearchConceptsHereditary hemorrhagic telangiectasiaSeptal dermoplastySeptal perforationQuality of lifeTransfusion requirementsHHT patientsHemorrhagic telangiectasiaMainstay of treatmentCentral nervous systemAutosomal dominant disorderMonopolar cauterizationGraft uptakeCommon manifestationMucocutaneous tissuesSubjective improvementEffective treatmentEpistaxisVisceral organsPatientsSeptectomyNervous systemAbnormal angiogenesisPatient resultsTelangiectasia formationCombined procedure
1980
Use of Selective Arteriography in the Treatment of Epistaxis
Rosnagle R, Allen W, Kier E, Rothman S. Use of Selective Arteriography in the Treatment of Epistaxis. JAMA Otolaryngology - Head & Neck Surgery 1980, 106: 137-142. PMID: 7356432, DOI: 10.1001/archotol.1980.00790270001001.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply